REPLReplimune Group, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+25% of shares).
Choppy, but holding above its 200-day average. Price is +25% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How REPL is trading
Replimune Group, Inc. is +41% over the past year while the S&P 500 is +16%: 25 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +25%
vs 200-day average · a clear uptrend
- RSI (14)
- 35
RSI (14) · neutral
- Below its 52-week high
- 28%
Below its 52-week high
Details›
- Last close2026-10-23
- $11.44
- 1 monthS&P 500 −0.94%
- −9.1%
- 1 yearS&P 500 +16%
- +41%
- 5 yearsS&P 500 +86%
- −63%
- vs 50-day average$13.53
- −15%
- 52-week high
- $15.97
- 52-week low
- $1.70
- Annualised volatility
- 187%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $474K
| Year | Return |
|---|---|
| 2026 (year to date) | +18% |
| 2025 | −20% |
| 2024 | +44% |
| 2023 | −69% |
| 2022 | +0.37% |
| 2021 | −29% |
| 2020 | +166% |
| 2019 | +44% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 5 of 8 | −1.4% |
| Feb | 8 | 3 of 8 | −5.1% |
| Mar | 8 | 2 of 8 | −8.8% |
| Apr | 8 | 4 of 8 | +2.1% |
| May | 8 | 4 of 8 | +26% |
| Jun | 8 | 7 of 8 | +23% |
| Jul | 8 | 3 of 8 | −7.7% |
| Aug | 9 | 4 of 9 | +6.3% |
| Sep | 9 | 2 of 9 | −6.4% |
| Oct | 9 | 5 of 9 | +22% |
| Nov | 8 | 5 of 8 | +3.6% |
| Dec | 8 | 2 of 8 | −8.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.